ACH-1095

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameACH-1095
Drug Alias NameNS4A protease inhibitors (Achillion/Gilead)ACH-0199GS-9525ACH-1095
ClassificationSmall molecules
Mechanisms of ActionHepatitis C virus replication inhibitorsHepatitis C virus serine protease, NS3/NS4A inhibitors
TargetsHepatitis C virus serine protease, NS3/NS4A
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAchillion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGilead Sciences IncAchillion Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A